Showing 1 - 20 results of 31 for search 'Maysaloun Merhi (4246147)', query time: 0.02s Refine Results
  1. 1
    The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update

    The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update by Maysaloun Merhi (4246147)

    Published 2023
    Save to List
    Saved in:
  2. 2
    Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report

    Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report by Maysaloun Merhi (4246147)

    Published 2018
    Save to List
    Saved in:
  3. 3
    Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer

    Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer by Said Dermime (79420)

    Published 2021
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  4. 4
    Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer

    Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer by Said Dermime (79420)

    Published 2021
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  5. 5
    Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

    Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity by Allan Relecom (14153295)

    Published 2021
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  6. 6
    Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

    Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy by Afsheen Raza (492657)

    Published 2022
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  7. 7
    Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan

    Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan by Sourour Idoudi (14153457)

    Published 2023
    Other Authors:
    Save to List
    Saved in:
  8. 8
    The role of PAK4 in the immune system and its potential implication in cancer immunotherapy

    The role of PAK4 in the immune system and its potential implication in cancer immunotherapy by Azza Naїja (17280610)

    Published 2021
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  9. 9
    Nano-vitamin C: A promising candidate for therapeutic applications

    Nano-vitamin C: A promising candidate for therapeutic applications by Takwa Bedhiafi (14153460)

    Published 2023
    Other Authors:
    Save to List
    Saved in:
  10. 10
    The potential role of vitamin C in empowering cancer immunotherapy

    The potential role of vitamin C in empowering cancer immunotherapy by Takwa Bedhiafi (14153460)

    Published 2022
    Other Authors:
    Save to List
    Saved in:
  11. 11
    Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target

    Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target by Queenie Fernandes (14557388)

    Published 2018
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  12. 12
    Role of HMGB1 and its associated signaling pathways in human malignancies

    Role of HMGB1 and its associated signaling pathways in human malignancies by Sourour Idoudi (14153457)

    Published 2023
    Other Authors:
    Save to List
    Saved in:
  13. 13
    Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways

    Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways by Hadeel Kheraldine (14231609)

    Published 2024
    Other Authors:
    Save to List
    Saved in:
  14. 14
    Applications of polydopaminic nanomaterials in mucosal drug delivery

    Applications of polydopaminic nanomaterials in mucosal drug delivery by Takwa Bedhiafi (14153460)

    Published 2023
    Other Authors:
    Save to List
    Saved in:
  15. 15
    Anti-cancer effects of Tranilast: An update

    Anti-cancer effects of Tranilast: An update by Soha Osman (17280655)

    Published 2021
    Other Authors:
    Save to List
    Saved in:
  16. 16
    CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

    CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances by Karama Makni Maalej (17821424)

    Published 2023
    Other Authors: “…Maysaloun Merhi (4246147)…”
    Save to List
    Saved in:
  17. 17
    Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia

    Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia by Shilpa Kuttikrishnan (3520079)

    Published 2019
    Other Authors:
    Save to List
    Saved in:
  18. 18
    Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation

    Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation by Kodappully S. Siveen (4246150)

    Published 2019
    Other Authors:
    Save to List
    Saved in:
  19. 19
    Selective induction of apoptosis in T-cell acute lymphoblastic leukemia by pristimerin through dual PI3K/AKT pathway inhibition and ROS generation

    Selective induction of apoptosis in T-cell acute lymphoblastic leukemia by pristimerin through dual PI3K/AKT pathway inhibition and ROS generation by Shilpa Kuttikrishnan (3520079)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  20. 20
    The apoptotic and anti‐proliferative effects of Neosetophomone B in T‐cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition

    The apoptotic and anti‐proliferative effects of Neosetophomone B in T‐cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition by Shilpa Kuttikrishnan (3520079)

    Published 2024
    Other Authors:
    Save to List
    Saved in:

Search Tools: